3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
15
Carcinoma, Non-Small-Cell Lung
14
Lung Neoplasms
5
Unspecified Adult Solid Tumor, Protocol Specific
3
Neoplasms
3
Uterine Cervical Neoplasms
2
Small Cell Lung Carcinoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia
2
Endometrial Neoplasms
2
Breast Neoplasms, Male
2
Waldenstrom Macroglobulinemia
1
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Paraganglioma, Extra-Adrenal
1
Nonhematologic Malignancies
1
Non-Squamous Non-Small Cell Lung Cancer
1
Neoplastic Cells, Circulating
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Meningeal Carcinomatosis
1
Malignant Solid Tumour
1
Interventions
Vinorelbine
1
Interferon alpha-2
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Advanced Neoplasm
×
Vinorelbine
×
Clear all
NCT00908869
2012-01-30
METRO1
Institut Paoli-Calmettes
Phase 1
Completed
30 enrolled